There was no significant difference in rate of hospitalization for heart failure between the use of GLP1R agonists and placebo (HR: 0.93, 95% CI: 0.83 to 1.04, P = 0.203) (Fig. 4). The gene discussed is GLP1R; the disease is heart failure.